Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
109.7 USD | -2.05% | -0.79% | -10.72% |
05-13 | US reclassification could drive fresh research funding into pot sector | RE |
05-07 | Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.72% | 7.06B | |
+31.37% | 588B | |
-2.90% | 364B | |
+20.36% | 326B | |
+5.38% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.72% | 167B | |
+0.16% | 161B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Earnings Flash (JAZZ) JAZZ PHARMACEUTICALS Reports Q1 Revenue $902M, vs. Street Est of $954.3M